Future Fields

@futurefieldsHQ

Using fruit flies 🪰 to make recombinant proteins. 🧬🧫 Helping scientists change the world.

🌎

Pinned
Future Fields
@futurefieldsHQ
Apr 30
Your strategic partner in breaking #biomanufacturing bottlenecks and rescuing protein projects 👨‍🔬 Erik (VP of Technical Operations) and Karina (Head of Quality) walks us through the process of protein manufacturing with the EntoEngine™ 🪰 and Instar 1.0 🏭
2
Future Fields
@futurefieldsHQ
Nov 5
Why are diagnostic antigens and enzymes a commercial bottleneck? Standard hosts like E. coli can struggle with complex antigens and enzymes that need precise folding, multi-subunit assembly, and PTMs. ➡️ Explore our latest article: bit.ly/4iWqtwZ
Future Fields
@futurefieldsHQ
Nov 2
Here’s to Canadian biotech! 🇨🇦 See you at Life Sciences Week in Vancouver! 👋 @lifesciences_bc Catch @M_AndersonBaron at Invest in BC presented by @LumiraVentures (Nov 3-4) to learn how our Drosophila-based EntoEngine platform scales complex recombinant proteins. 🪰
Future Fields
@futurefieldsHQ
Oct 29
Part 2 of our Crop Trait article on Herbicide Tolerance (HT) traits and enzymes is live! Discover how trait developers are overcoming recombinant expression, assembly, and purification bottlenecks across major commercial HT enzyme classes. Read here 👉 hubs.li/Q04CGZt70
GIF
Future Fields
@futurefieldsHQ
Oct 27
How is reagent volatility shaping IVD? While antibodies scale, complex antigens and enzymes hit severe bottlenecks. 🧬 Learn how to build a resilient supply chain 👉 hubs.li/Q04CppSd0
GIF

Future Fields’s posts